Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Clinical Rheumatology|January 30, 2025
ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritisGüllü Sandal Uzun, Yasin Sarıkaya, Sevtap Arslan, et al.
International Journal of Rheumatic Diseases|August 28, 2018
Pulmonary hypertension in Takayasu arteritisAlper Sari, Yusuf Z Sener, Esra Firat, et al.
Medicine|June 3, 2010
Familial Mediterranean fever and central nervous system involvement: a case seriesUmut Kalyoncu, Amber Eker, Kader K Oguz, et al.
Biomarkers in Medicine|June 7, 2018
Blood group 'A' may have a possible modifier effect on familial Mediterranean fever and blood group '0' may be associated with colchicine resistanceAbdulsamet Erden, Ezgi Deniz Batu, Berkan Armagan, et al.
Clinical and Experimental Rheumatology|September 10, 2019
Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: real-life results from the HURBIO registryEmre Bilgin, Bayram Farisoğulları, Berkan Armağan, et al.
Clinical and Experimental Rheumatology|February 26, 2021
Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO RegistryBayram Farisoğulları, Gözde Kübra Yardımcı, Alper Sarı, et al.
The Journal of Rheumatology|July 3, 2015
Assessment of Patients with Takayasu Arteritis in Routine Practice with Indian Takayasu Clinical Activity ScoreFatma Alibaz-Oner, Sibel Z Aydin, Servet Akar, et al.
Rheumatology (Oxford, England)|June 15, 2010
Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-TakayasuSibel Z Aydin, Neslihan Yilmaz, Servet Akar, et al.
Turkish Journal of Medical Sciences|September 27, 2020
Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experienceEmre Bilgin, Furkan Ceylan, Emine Duran, et al.
Current Medical Research and Opinion|March 28, 2025
Comparison of functionality, mood, and biopsychosocial status in rheumatic patients with and without self-reported bowel problems and the evaluation of BETY's impact on these factors: a retrospective studyNur Banu Karaca, Aysu Kahraman, Sinan Buran, et al.
Pageof 14